BMJ, doi: 10.1136/bmj.38611.658947.55, (Published 10 October 2005)

PAPERS

Meta-analysis of MTHFR 677CT polymorphism and coronary heart disease: does totality of evidence support causal role for homocysteine and preventive potential of folate?

Sarah J Lewis ^1*, Shah Ebrahim ¹, George Davey Smith ¹

¹ Department of Social Medicine, University of Bristol, Bristol BS8 2PR

^* Correspondence to: s.j.lewis{at}bristol.ac.uk.

Objectives To investigate the association between the MTHFR 677CT polymorphism and coronary heart disease, assessing small study bias and heterogeneity between studies.

Data sources Medline and Embase citation searches between January 2001 and August 2004; no language restrictions.

Study selection Case-control and prospective studies of association between MTHFR 677CT variant and myocardial infarction, coronary artery occlusion, or both; 80 studies were included.

Data extraction Data on genotype frequency and mean homocysteine concentrations by genotype were extracted. Odds ratios were calculated for TT genotype versus CC genotype. Heterogeneity was explored, with stratification by geographical region of the study samples, and meta-regression by difference in mean serum homocysteine concentrations (CC minus TT genotypes) was carried out.

Results 26 000 cases and 31 183 controls were included. An overall random effects odds ratio of 1.14 (95% confidence intervals 1.05 to 1.24) was found for TT versus CC genotype. There was strong evidence of heterogeneity (P<0.001, I²=38.4%), which largely disappeared after stratification by geographical region. Odds ratios in Europe, Australia, and North America attenuated towards the null, unlike those in the Middle East and Asia.

Conclusions No strong evidence exists to support an association of the MTHFR 677 CT polymorphism and coronary heart disease in Europe, North America, or Australia. Geographical variability may be due to higher folate intake in North America and Europe or to publication bias. The conclusion drawn from previous meta-analyses that folic acid, through lowering homocysteine, has a role in prevention of cardiovascular disease is in some doubt.

---

(Accepted 19 August 2005)
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence

David S Wald, Nicholas J Wald, Joan K Morris, and Malcolm Law
BMJ 2006 333: 1114-1117. [Full Text] [PDF]

Role of folate in preventing CHD may be in doubt
BMJ 2005 331: 0. [Full Text]

Measuring inconsistency in meta-analyses

Julian P T Higgins, Simon G Thompson, Jonathan J Deeks, and Douglas G Altman
BMJ 2003 327: 557-560. [Extract] [Full Text] [PDF]

A strategy to reduce cardiovascular disease by more than 80%

N J Wald and M R Law
BMJ 2003 326: 1419. [Abstract] [Full Text] [PDF]

Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis

David S Wald, Malcolm Law, and Joan K Morris
BMJ 2002 325: 1202-1206. [Abstract] [Full Text] [PDF]

Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials

Homocysteine Lowering Trialists' Collaboration
BMJ 1998 316: 894-898. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

• Ebbing, M., Bleie, O., Ueland, P. M., Nordrehaug, J. E., Nilsen, D. W., Vollset, S. E., Refsum, H., Ringdal Pedersen, E. K., Nygard, O. (2008). Mortality and Cardiovascular Events in Patients Treated With Homocysteine-Lowering B Vitamins After Coronary Angiography: A Randomized Controlled Trial. JAMA 300: 795-804 [Abstract] [Full text]  
• Yang, Q.-H., Botto, L. D, Gallagher, M., Friedman, J., Sanders, C. L, Koontz, D., Nikolova, S., Erickson, J D., Steinberg, K. (2008). Prevalence and effects of gene-gene and gene-nutrient interactions on serum folate and serum total homocysteine concentrations in the United States: findings from the third National Health and Nutrition Examination Survey DNA Bank. Am. J. Clin. Nutr. 88: 232-246 [Abstract] [Full text]  
• Thompson, A., Di Angelantonio, E., Sarwar, N., Erqou, S., Saleheen, D., Dullaart, R. P. F., Keavney, B., Ye, Z., Danesh, J. (2008). Association of Cholesteryl Ester Transfer Protein Genotypes With CETP Mass and Activity, Lipid Levels, and Coronary Risk. JAMA 299: 2777-2788 [Abstract] [Full text]  
• Marini, N. J., Gin, J., Ziegle, J., Keho, K. H., Ginzinger, D., Gilbert, D. A., Rine, J. (2008). The prevalence of folate-remedial MTHFR enzyme variants in humans. Proc. Natl. Acad. Sci. USA 105: 8055-8060 [Abstract] [Full text]  
• Crowe, F. L., Skeaff, C. M., McMahon, J. A., Williams, S. M., Green, T. J. (2008). Lowering Plasma Homocysteine Concentrations of Older Men and Women with Folate, Vitamin B-12, and Vitamin B-6 Does Not Affect the Proportion of (n-3) Long Chain Polyunsaturated Fatty Acids in Plasma Phosphatidylcholine. J. Nutr. 138: 551-555 [Abstract] [Full text]  
• Bennet, A. M., Di Angelantonio, E., Ye, Z., Wensley, F., Dahlin, A., Ahlbom, A., Keavney, B., Collins, R., Wiman, B., de Faire, U., Danesh, J. (2007). Association of Apolipoprotein E Genotypes With Lipid Levels and Coronary Risk. JAMA 298: 1300-1311 [Abstract] [Full text]  
• Baigent, C., Clarke, R. (2007). B Vitamins for the Prevention of Vascular Disease: Insufficient Evidence to Justify Treatment. JAMA 298: 1212-1214 [Full text]  
• Zittan, E., Preis, M., Asmir, I., Cassel, A., Lindenfeld, N., Alroy, S., Halon, D. A., Lewis, B. S., Shiran, A., Schliamser, J. E., Flugelman, M. Y. (2007). High frequency of vitamin B12 deficiency in asymptomatic individuals homozygous to MTHFR C677T mutation is associated with endothelial dysfunction and homocysteinemia. Am. J. Physiol. Heart Circ. Physiol. 293: H860-H865 [Abstract] [Full text]  
• Arnett, D. K., Baird, A. E., Barkley, R. A., Basson, C. T., Boerwinkle, E., Ganesh, S. K., Herrington, D. M., Hong, Y., Jaquish, C., McDermott, D. A., O'Donnell, C. J. (2007). Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 115: 2878-2901 [Abstract] [Full text]  
• Yang, Q.-H., Carter, H. K, Mulinare, J., Berry, R., Friedman, J., Erickson, J D. (2007). Race-ethnicity differences in folic acid intake in women of childbearing age in the United States after folic acid fortification: findings from the National Health and Nutrition Examination Survey, 2001-2002. Am. J. Clin. Nutr. 85: 1409-1416 [Abstract] [Full text]  
• Ueland, P. M., Clarke, R. (2007). Homocysteine and Cardiovascular Risk: Considering the Evidence in the Context of Study Design, Folate Fortification, and Statistical Power. Clin. Chem. 53: 807-809 [Full text]  
• Ntzani, E. E., Rizos, E. C., Ioannidis, J. P. A. (2007). Genetic Effects versus Bias for Candidate Polymorphisms in Myocardial Infarction: Case Study and Overview of Large-Scale Evidence. Am J Epidemiol 165: 973-984 [Abstract] [Full text]  
• Zee, R. Y.L., Mora, S., Cheng, S., Erlich, H. A., Lindpaintner, K., Rifai, N., Buring, J. E., Ridker, P. M (2007). Homocysteine, 5,10-Methylenetetrahydrofolate Reductase 677C>T Polymorphism, Nutrient Intake, and Incident Cardiovascular Disease in 24 968 Initially Healthy Women. Clin. Chem. 53: 845-851 [Abstract] [Full text]  
• Bathum, L., Petersen, I., Christiansen, L., Konieczna, A., Sorensen, T. I.A., Kyvik, K. O. (2007). Genetic and Environmental Influences on Plasma Homocysteine: Results from a Danish Twin Study. Clin. Chem. 53: 971-979 [Abstract] [Full text]  
• Hajer, G. R, van der Graaf, Y., Olijhoek, J. K, Verhaar, M. C, Visseren, F. L J, for the SMART Study Group, (2007). Levels of homocysteine are increased in metabolic syndrome patients but are not associated with an increased cardiovascular risk, in contrast to patients without the metabolic syndrome. Heart 93: 216-220 [Abstract] [Full text]  
• Gilbody, S., Lewis, S., Lightfoot, T. (2007). Methylenetetrahydrofolate Reductase (MTHFR) Genetic Polymorphisms and Psychiatric Disorders: A HuGE Review. Am J Epidemiol 165: 1-13 [Abstract] [Full text]  
• Wald, D. S, Wald, N. J, Morris, J. K, Law, M. (2006). Folic acid, homocysteine, and cardiovascular disease: judging causality in the face of inconclusive trial evidence. BMJ 333: 1114-1117 [Full text]  
• Reed, M. C., Nijhout, H. F., Neuhouser, M. L., Gregory, J. F. III, Shane, B., James, S. J., Boynton, A., Ulrich, C. M. (2006). A Mathematical Model Gives Insights into Nutritional and Genetic Aspects of Folate-Mediated One-Carbon Metabolism. J. Nutr. 136: 2653-2661 [Abstract] [Full text]  
• de Craen, A. J.M., Stott, D. J., Westendorp, R. G.J., Khare, A., Lopez, M., Gogtay, J., Quinlivan, E. P., Gregory, J. F. III, Refsum, H., Smith, A. D., Wang, X., Demirtas, H., Xu, X., Tomlinson, D. R., Lang, D., Lewis, M. J., Lonn, E., the HOPE-2 Investigators, , Bonaa, K. H., Tverdal, A., Ueland, P. M. (2006). Homocysteine, B vitamins, and cardiovascular disease.. NEJM 355: 205-206 [Full text]  
• Refsum, H., Nurk, E., Smith, A. D., Ueland, P. M., Gjesdal, C. G., Bjelland, I., Tverdal, A., Tell, G. S., Nygard, O., Vollset, S. E. (2006). The Hordaland Homocysteine Study: A Community-Based Study of Homocysteine, Its Determinants, and Associations with Disease. J. Nutr. 136: 1731S-1740S [Abstract] [Full text]  
• Bosco, P., Anello, G., Ferri, R., Gueant-Rodriguez, R.-M., Gueant, J.-L., Cronin, S., Kelly, P. (2006). Heterogeneity of Association Between MTHFR and Stroke Among European Regions: Additional Population Studies Are Needed in Italy. Stroke 37: 761-762 [Full text]  
• Lowe, G. D.O. (2006). The association between elevated levels of inflammation biomarkers and coronary artery disease and death.. CMAJ 174: 479-480 [Full text]  

Rapid Responses:

Read all Rapid Responses

Homocysteine and endothelial oxidative stress

Andrew McCaddon, MD, et al.
bmj.com, 19 Oct 2005 [Full text]

Homocysteine: Folate is Not Enough.

Eddie Vos, et al.
bmj.com, 22 Oct 2005 [Full text]

to perish, to publish, to haste, too...

Ivan Y. Torshin
bmj.com, 25 May 2006 [Full text]